AMBER THOMAS: Open Payments
NPI 1194490482 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,539 in 166 payments from 21 companies in 2025. Trend: 2023 $2,813 · 2024 $2,396 · 2025 $2,539
Food & beverage: $2,539
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $530 |
| ABBVIE INC. | 43 | $316 |
| Kowa Pharmaceuticals America, Inc. | 16 | $255 |
| Corcept Therapeutics | 6 | $248 |
| Sumitomo Pharma America, Inc. | 19 | $203 |
| Amgen Inc. | 14 | $156 |
| Lilly USA, LLC | 11 | $137 |
| Otsuka America Pharmaceutical, Inc. | 5 | $118 |
| PFIZER INC. | 4 | $71 |
| Exact Sciences Corporation | 3 | $65 |
Products named: Auvelity, ZORYVE, Korlym, GEMTESA, REXULTI, QULIPTA, MOUNJARO, VRAYLAR.
Industry payments across TX — which companies pay providers there.
